Welding and Parkinsonism

Neurologic Clinics

Volumn 29, Issue 3, 2011, Pages 623-640

  Furbee, Brent ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Manganese; Manganism; Parkinsonism; Welders; Welding

Indexed keywords

EDETIC ACID; MANGANESE; STEEL;

AEROSOL; BRADYKINESIA; CONCENTRATION (PARAMETERS); DYSPHONIA; EQUIPMENT; HALLUCINATION; HEADACHE; HEALTH HAZARD; HEAT; HEATING; HUMAN; INDUSTRIAL WORKER; INTOXICATION; MANGANISM; MELTING POINT; MUSCLE RIGIDITY; NERVE DEGENERATION; NEUROPHYSIOLOGY; OCCUPATIONAL EXPOSURE; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAILWAY; REVIEW; SEXUAL DYSFUNCTION; SLEEP DISORDER; SLURRED SPEECH; TREMOR; WELDING; WORKPLACE;

HUMANS; MANGANESE; MANGANESE POISONING; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PARKINSON DISEASE, SECONDARY; WELDING;

EID: 79960762766     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2011.05.007     Document Type: Review

References (92)

1. Antonini J.M., Stone S., Roberts J.R., et al. Effect of short-term stainless steel welding fume inhalation exposure on lung inflammation, injury, and defense responses in rats. Toxicol Appl Pharmacol 2007, 223(3):234-245.
2. Bureau of Labor Statistics, Welding, soldering, and brazing workers, in Occupational Outlook Handbook. 2010-2011, U.S. Department of Labor Available at:, Accessed April 28, 2011. http://www.bls.gov/oco/ocos226.htm.
3. Britton J., Walsh E. Health hazards of electric and gas welding. J Ind Hyg Toxicol 1940, 22:125-151.
4. Couper J. On the effects of black oxide of manganese when inhaled into the lungs. British Annals of Medicine and Pharmacology, Vital Statistics and General Science 1837, I:41-42.
5. Edsall D., Wilbur P., Drinker C. The occurrence, course, and prevention of chronic manganese poisoning. J Indust Hyg 1919, 1:183.
6. Embden H. Zur Kenntnis der metalischen Nervengifte (Ueber die chronische Manganveriftung der Braunsteinmuller). Deutsch Med Wehnschr 1901, 27:795. [in French].
7. Von Jaksch R. On manganese toxicoses and manganese phobia. Munch Med Wochenschr 1907, 20:969-972.
8. Casamajor L. An unusual form of mineral poisoning affecting the nervous system: manganese?. JAMA 1913, 60(9):646-649.
9. Ashizawa R. Autopsy report on a case involving chronic manganese poisoning. Japanese J Med Sci VII 1930, I:173-191.
10. Parnitzke K., Peiffer J. On the characteristics and pathological anatomy of chronic manganese poisoning. Arch Psych Neurol Disord (J Neurol Psychiatry) 1954, 192:404-429.
11. Canavan M., Cobb S., Drinker C. Chronic manganese poisoning. Arch Neurol 1934, 32:501-513.
12. Rodier J. Manganese poisoning in Moroccan miners. Br J Ind Med 1955, 12(1):21-35.
13. Abd el Naby S., Hassanein M. Neuropsychiatric manifestations of chronic manganese poisoning. J Neurol Neurosurg Psychiatr 1965, 28:282.
14. Wang J.D., Huang C.C., Hwang Y.H., et al. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med 1989, 46(12):856-859.
15. Huang C.C., Chu N.S., Lu C.S., et al. Chronic manganese intoxication. Arch Neurol 1989, 46(10):1104-1106.
16. Huang C.C., Chu N.S., Lu C.S., et al. Long-term progression in chronic manganism: ten years of follow-up. Neurology 1998, 50(3):698-700.
17. Huang C.C., Lu C.S., Chu N.S., et al. Progression after chronic manganese exposure. Neurology 1993, 43(8):1479-1483.
18. Lu C.S., Huang C.C., Chu N.S., et al. Levodopa failure in chronic manganism. Neurology 1994, 44(9):1600-1602. [see comment].
19. Huang C-C., Weng Y-H., Lu C-S., et al. Dopamine transporter binding in chronic manganese intoxication. J Neurol 2003, 250(11):1335-1339.
20. Beintker E. The effect of manganese during arc welding. Zentralblatt Gewerbehygiene 1932, 9:207-211.
21. McMillan G. Is electric arc welding linked to manganism or Parkinson's disease?. Toxicol Rev 2005, 24(4):237-257.
22. Oltramare M., Tchicaloff M., Desbaumes P., et al. Chronic manganese poisoning in two arc welders. Int Arch Gewerbepathol Gewerbehyg 1965, 21:124-140.
23. Nelson K., Golnick J., Korn T., et al. Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Ind Med 1993, 50(6):510-513.
24. Discalzi G., Pira E., Herrero Hernandez E., et al. Occupational Mn parkinsonism: magnetic resonance imaging and clinical patterns following CaNa2-EDTA chelation. Neurotoxicology 2000, 21(5):863-866.
25. Sato K., Ueyama H., Arakawa R., et al. Rinsho Shinkeigaku 2000, 40(11):1110-1115. [in Japanese].
26. Ono K., Komai K., Yamada M. Myoclonic involuntary movement associated with chronic manganese poisoning. J Neurol Sci 2002, 199(1-2):93-96.
27. Sadek A.H., Rauch R., Schulz P.E. Parkinsonism due to manganism in a welder. Int J Toxicol 2003, 22(5):393-401.
28. Bowler R.M., Koller W., Schulz P.E. Parkinsonism due to manganism in a welder: neurological and neuropsychological sequelae. Neurotoxicology 2006, 27(3):327-332.
29. Kenangil G., Ertan S., Sayilir I., et al. Progressive motor syndrome in a welder with pallidal T1 hyperintensity on MRI: a two-year follow-up. Mov Disord 2006, 21(12):2197-2200.
30. Stobbaerts R.F., Ieven M., Deelstra H., et al. Mn-content of total parenteral and enteral nutrition. Z Ernahrungswiss 1992, 31(2):138-146.
31. Roels H., Meiers G., Delos M., et al. Influence of the route of administration and the chemical form (MnCl2, MnO2) on the absorption and cerebral distribution of manganese in rats. Arch Toxicol 1997, 71(4):223-230.
32. Jenkins N., Eagar T. Chemical analysis of welding fume particles. Welding J 2005, 84:87s-93s.
33. Dickinson D., Lippold J. Analysis of welding fume from E6010 and E308-16 electrodes 2004, D&L Welding Fume Analysis, LLC, Dublin (OH), p. 1-64.
34. Dickinson D., Lippold J. Analysis of welding fume from Lincore M Electrodes 2005, D&L Welding Fume Analysis, LLC, Dublin (OH), p. 1-37.
35. Lippold J., Dickinson D. Analysis of welding fume from Tri-mark 771 Electrodes 2005, D&L Welding Fume Analysis, LLC, Dublin (OH), p. 1-37.
36. Bush V.J., Moyer T.P., Batts K.P., et al. Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues. Clin Chem 1995, 41(2):284-294.
37. Crossgrove J.S., Yokel R.A. Manganese distribution across the blood-brain barrier. IV. Evidence for brain influx through store-operated calcium channels. Neurotoxicology 2005, 26(3):297-307.
38. Aschner M., Guilarte T.R., Schneider J.S., et al. Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol 2007, 221(2):131-147.
39. Murphy V.A., Wadhwani K.C., Smith Q.R., et al. Saturable transport of manganese(II) across the rat blood-brain barrier. J Neurochem 1991, 57(3):948-954.
40. Wadhwani K.C., Murphy V.A., Smith Q.R., et al. Saturable transport of manganese(II) across blood-nerve barrier of rat peripheral nerve. Am J Physiol 1992, 262(2 Pt 2):R284-R288.
41. Yokel R.A., Crossgrove J.S., Bukaveckas B.L. Manganese distribution across the blood-brain barrier. II. Manganese efflux from the brain does not appear to be carrier mediated. Neurotoxicology 2003, 24(1):15-22.
42. Smith D., Gwiazda R., Bowler R., et al. Biomarkers of Mn exposure in humans. Am J Ind Med 2007, 50(11):801-811.
43. Mahoney J.P., Small W.J. Studies on manganese. 3. The biological half-life of radiomanganese in man and factors which affect this half-life. J Clin Invest 1968, 47(3):643-653.
44. Mena I., Horiuchi K., Burke K., et al. Chronic manganese poisoning. Individual susceptibility and absorption of iron. Neurology 1969, 19(10):1000-1006.
45. 54Mn in the monkey: studies of different parts of the central nervous system and other organs. J Clin Invest 1971, 50(1):9-20.
46. Newland M.C., Cox C., Hamada R., et al. The clearance of manganese chloride in the primate. Fund Appl Toxicol 1987, 9(2):314-328.
47. Gibbons R.A., Dixon S.N., Hallis K., et al. Manganese metabolism in cows and goats. Biochim Biophys Acta 1976, 444(1):1-10.
48. Borg D.C., Cotzias G.C. Incorporation of manganese into erythrocytes as evidence for a manganese porphyrin in man. Nature 1958, 182(4650):1677-1678.
49. Roels H., Sarhan M.J., Hanotiau I., et al. Preclinical toxic effects of manganese in workers from a Mn salts and oxides producing plant. Sci Total Environ 1985, 42(1/2):201-206.
50. Roels H.A., Ortega Eslava M.I., Ceulemans E., et al. Prospective study on the reversibility of neurobehavioral effects in workers exposed to manganese dioxide. Neurotoxicology 1999, 20(2/3):255-271.
51. Crump K.S., Rousseau P. Results from eleven years of neurological health surveillance at a manganese oxide and salt producing plant. Neurotoxicology 1999, 20(2/3):273-286.
52. Racette B.A., McGee-Minnich L., Moerlein S.M., et al. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology 2001, 56(1):8-13. [see comment].
53. Racette B.A., Tabbal S.D., Jennings D., et al. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology 2005, 64(2):230-235.
54. Bowler R.M., Gysens S., Diamond E., et al. Manganese exposure: neuropsychological and neurological symptoms and effects in welders. Neurotoxicology 2006, 27(3):315-326.
55. Bowler R.M., Roels H.A., Nakagawa S., et al. Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occup Environ Med 2007, 64(3):167-177.
56. Bowler R.M., Nakagawa S., Drezgic M., et al. Sequelae of fume exposure in confined space welding: a neurological and neuropsychological case series. Neurotoxicology 2007, 28(2):298-311.
57. Zoni S., Albini E., Lucchini R. Neuropsychological testing for the assessment of manganese neurotoxicity: a review and a proposal. Am J Ind Med 2007, 50(11):812-830.
58. Meyer-Baron M., Knapp G., Schäper M., et al. Performance alterations associated with occupational exposure to manganese-a meta-analysis. Neurotoxicology 2009, 30(4):487-496.
59. Greiffenstein M.F., Lees-Haley P.R. Neuropsychological correlates of manganese exposure: a meta-analysis. J Clin Exp Neuropsychol 2007, 29(2):113-126.
60. Fryzek J., Hansen J., Cohen S., et al. A cohort study of Parkinson's disease and other neurodegenerative disorders in Danish welders. J Occup Environ Med 2005, 47:466-472.
61. Park R.M., Schulte P.A., Bowman J.D., et al. Potential occupational risks for neurodegenerative diseases. Am J Ind Med 2005, 48(1):63-77.
62. Fored C.M., Fryzek J.P., Brandt L., et al. Parkinson's disease and other basal ganglia or movement disorders in a large nationwide cohort of Swedish welders. Occup Environ Med 2006, 63(2):135-140.
63. Dick F., De Palma G., Ahmadi A., et al. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study. Occup Environ Med 2007, 64(10):666-672.
64. Marsh G., Gula M. Employment as a welder and Parkinson Disease among heavy equipment manufacturing workers. J Occup Environ Med 2006, 48(10):1031-1046.
65. Stampfer M. Welding occupations and mortality from Parkinson's disease and other neurodegenerative diseases among United States men, 1985-1999. J Occup Environ Hyg 2009, 6:267-272.
66. Baek S.Y., Lee M.J., Jung H.S. Effect of manganese exposure on MPTP neurotoxicities. Neurotoxicology 2003, 24(4-5):657-665.
67. Park R.M., Bowler R.M., Roels H.A. Exposure-response relationship and risk assessment for cognitive deficits in early welding-induced manganism. J Occup Environ Med 2009, 51(10):1125-1136.
68. Buchet J.P., Lauwerys R., Roels H., et al. Determination of manganese in blood and urine by flameless atomic absorption spectrophotometry. Clin Chim Acta 1976, 73(3):481-486.
69. Allain P., Mauras Y., Premel-Cabic A., et al. Effects of an EDTA infusion on the urinary elimination of several elements in healthy subjects. Br J Clin Pharmacol 1991, 31(3):347-349.
70. Cranton E., Liu Z., Smith I. Urinary trace and toxic elements and minerals in untimed urine specimens relative to urine creatinine, Part I: concentrations of elements in fasting urine. Journal of Advancement in Medicine 1989, 2(1):331-349.
71. Sata F., Araki S., Murata K., et al. Behavior of heavy metals in human urine and blood following calcium disodium ethylenediamine tetraacetate injection: observations in metal workers. J Toxicol Environ Health A 1998, 54(3):167-178.
72. Barceloux D. Manganese. Clin Toxicol 1999, 37(2):293-307.
73. Anonymous ARUP's Laboratory Test Directory Available at:, Accessed February 14, 2011. http://www.aruplab.com/guides/ug/tests/0099265.jsp.
74. Anonymous. Mayo Medical Laboratory. Rochester (MN): Mayo Clinic; 2011. Available at: Accessed February 14, 2011. http://www.mayomedicallaboratories.com/testcatalog/Clinical+and+Interpretive/89120.
75. Anonymous LabCorp, Laboratory Corporation of America, Test Menu Available at:, Accessed February 14, 2011. https://www.labcorp.com/wps/portal/provider/testmenu/.
76. Shinotoh H., Snow B.J., Hewitt K.A. MRI and PET studies of manganese-intoxicated monkeys. Neurology 1995, 45(6):1199-1204.
77. Uchino A., Noguchi T., Nomiyama K., et al. Manganese accumulation in the brain: MR imaging. Neuroradiology 2007, 49(9):715-720.
78. Hauser R.A., Zesiewicz T.A., Martinez C., et al. Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Can J Neurol Sci 1996, 23(2):95-98.
79. Krieger D., Krieger S., Jansen O., et al. Manganese and chronic hepatic encephalopathy. Lancet 1995, 346(8970):270-274.
80. Nagatomo S., Umehara F., Hanada K., et al. Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. J Neurol Sci 1999, 162(1):102-105.
81. Ono J., Harada K., Kodaka R., et al. Manganese deposition in the brain during long-term total parenteral nutrition. JPEN J Parenter Enteral Nutr 1995, 19(4):310-312.
82. Selikhova M., Fedoryshyn L., Matviyenko Y., et al. Parkinsonism and dystonia caused by the illicit use of ephedrone-a longitudinal study. Mov Disord 2008, 23(15):2224-2231.
83. Stepens A., Logina I., Liguts V., et al. A Parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med 2008, 358(10):1009-1017.
84. Dietz M.C., Ihrig A., Wrazidlo W., et al. Results of magnetic resonance imaging in long-term manganese dioxide-exposed workers. Environ Res 2001, 85(1):37-40.
85. Kim Y., Kim J.W., Ito K., et al. Idiopathic parkinsonism with superimposed manganese exposure: utility of positron emission tomography. Neurotoxicology 1999, 20(2-3):249-252.
86. Josephs K.A., Ahlskog J.E., Klos K.J., et al. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology 2005, 64(12):2033-2039. [see comment].
87. Neiman J., Haapaniemi H.M., Hillbom M. Neurological complications of drug abuse: pathophysiological mechanisms. Eur J Neurol 2000, 7(6):595-606.
88. Huang C.C. Parkinsonism induced by chronic manganese intoxication-an experience in Taiwan. Chang Gung Med J 2007, 30(5):385-395.
89. Huang C.C., Chu N.S., Lu C.S., et al. The natural history of neurological manganism over 18 years. Parkinsonism Relat Disord 2007, 13(3):143-145.
90. Chang Y., Woo S-T., Kim Y., et al. Pallidal index measured with three-dimensional T1-weighted gradient echo sequence is a good predictor of manganese exposure in welders. J Magn Reson Imaging 2010, 31(4):1020-1026.
91. Kim E., Kim Y., Cheong H-K., et al. Pallidal index on MRI as a target organ dose of manganese: structural equation model analysis. Neurotoxicology 2005, 26(3):351-359.
92. Herrero Hernandez E., Discalzi G., Valentini C., et al. Follow-up of patients affected by manganese-induced parkinsonism after treatment with CaNa2EDTA. Neurotoxicology 2006, 27(3):333-339.